HCPCS J9349 — Inj., tafasitamab-cxix (2026 RVU Values)

HCPCS code J9349 (Inj., tafasitamab-cxix) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.

Related references